These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 5441544)

  • 1. Warfarin metabolism in man: identification of metabolites in urine.
    Lewis RJ; Trager WF
    J Clin Invest; 1970 May; 49(5):907-13. PubMed ID: 5441544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bioavailability of Drugs-The Current State of Knowledge.
    Stielow M; Witczyńska A; Kubryń N; Fijałkowski Ł; Nowaczyk J; Nowaczyk A
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.
    Marie S; Frost KL; Hau RK; Martinez-Guerrero L; Izu JM; Myers CM; Wright SH; Cherrington NJ
    Acta Pharm Sin B; 2023 Jan; 13(1):1-28. PubMed ID: 36815037
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cheng S; Flora DR; Rettie AE; Brundage RC; Tracy TS
    Drug Metab Dispos; 2022 Jul; 50(9):1302-11. PubMed ID: 35798368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity.
    El-Haj BM; Ahmed SBM; Garawi MA; Ali HS
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30142909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy.
    Bosch LA
    J Pharmacogenomics Pharmacoproteomics; 2014 Jan; 5(1):. PubMed ID: 25285240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites.
    Haque JA; McDonald MG; Kulman JD; Rettie AE
    Blood; 2014 Jan; 123(4):582-9. PubMed ID: 24297869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of oral anticoagulants: a basis for dose individualization.
    Stehle S; Kirchheiner J; Lazar A; Fuhr U
    Clin Pharmacokinet; 2008; 47(9):565-94. PubMed ID: 18698879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tanshinone IIA on the noncovalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry.
    Liu J; Wang X; Cai Z; Lee FS
    J Am Soc Mass Spectrom; 2008 Oct; 19(10):1568-75. PubMed ID: 18657993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
    Ufer M
    Clin Pharmacokinet; 2005; 44(12):1227-46. PubMed ID: 16372822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological importance of stereochemical resolution of enantiomeric drugs.
    Islam MR; Mahdi JG; Bowen ID
    Drug Saf; 1997 Sep; 17(3):149-65. PubMed ID: 9306051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sertraline on protein binding of warfarin.
    Apseloff G; Wilner KD; Gerber N; Tremaine LM
    Clin Pharmacokinet; 1997; 32 Suppl 1():37-42. PubMed ID: 9068934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.
    Chan E; McLachlan AJ; Pegg M; MacKay AD; Cole RB; Rowland M
    Br J Clin Pharmacol; 1994 Jun; 37(6):563-9. PubMed ID: 7917775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species.
    Davis PJ; Rizzo JD
    Appl Environ Microbiol; 1982 Apr; 43(4):884-90. PubMed ID: 7081986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.
    Spahn H; Kirch W; Mutschler E; Ohnhaus EE; Kitteringham NR; Lögering HJ; Paar D
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):97S-102S. PubMed ID: 6743480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between warfarin and propranolol.
    Scott AK; Park BK; Breckenridge AM
    Br J Clin Pharmacol; 1984 May; 17(5):559-64. PubMed ID: 6733003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions with warfarin.
    Serlin MJ; Breckenridge AM
    Drugs; 1983 Jun; 25(6):610-20. PubMed ID: 6347619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis.
    Heni N; Glogner P
    Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):183-6. PubMed ID: 958506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.
    Drayer DE
    Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.